Formulary Chapter 1: Gastro-intestinal system - Full Chapter
01.01
Dyspepsia and gastro-oesophageal reflux disease
01.01
Dyspepsia
01.01
Gastro-oesophageal reflux disease
01.01.01
Antacids and simeticone
01.01.01
Aluminium and magnesium containing antacids
01.01.01
Antacid preparations containing simeticone
01.01.01
Simeticine alone
01.01.01
Antacid preparations containing dimeticone or local anaesthetics
01.01.02
Compound alginates and proprietary indigestion preparations
01.01.02
Compound alginate preparations
01.02
Antispasmodics and other drugs altering gut motility
01.02
Antimuscarinics
01.02
Other antispasmodics
01.02
Motility stimulants
01.03
Antisecretory drugs and mucosal protectants
01.03
Helicobacter pylori infection
01.03
NSAID-associated ulcers
01.03.01
H2-receptor antagonists
01.03.02
Selective antimuscarinics
01.03.03
Chelates and complexes
01.03.04
Prostaglandin analogues
01.03.05
Proton pump inhibitors (PPIs)
01.03.06
Other ulcer-healing drugs
01.04
Acute diarrhoea
01.04.01
Adsorbents and bulk-forming drugs
01.04.02
Antimotility drugs
01.04.03
Enkephalinase Inhibitors
01.05
Chronic bowel disorders
01.05
Irritable bowel syndrome
01.05
Malabsorption syndromes
01.05
Inflammatory bowel disease
01.05
Antibiotic-associated colitis
01.05
Diverticular disease
01.05.01
Aminosalicylates
01.05.02
Corticosteroids
01.05.02
Oral
01.05.03
Drugs affecting the immune response
01.05.03
Cytokine inhibitors
01.05.03
Vedolizumab
01.05.04
Food allergy
01.06
Laxatives
01.06.01
Bulk-forming laxatives
01.06.02
Stimulant laxatives
01.06.02
Other Stimulant laxatives
01.06.03
Faecal softeners
01.06.04
Osmotic laxatives
01.06.05
Bowel cleansing preparations
Used prior to colonic surgery, colonoscopy or radiological examination
01.06.06
Peripheral opiod-receptor antagonist
01.06.07
5HT4 receptor agonists and guanylate cyclase-C receptor agonists
01.07
Local preparations for anal and rectal disorders
01.07.01
Soothing haemorrhoidal preparations
01.07.02
Compound haemorrhoidal preparations with corticosteroids
01.07.03
Rectal sclerosants
01.07.04
Management of anal fissures
01.09
Drugs affecting intestinal secretions
01.09.01
Drugs affecting biliary composition and flow
01.09.01
Other prepatations for biliary disorders
01.09.02
Bile acid sequestrants
01.09.03
Aprotinin
01.09.04
Pancreatin
....
Key
Notes
Section Title (top level)
Section Title (sub level)
First Choice item
Non Formulary section
Restricted Drug
Unlicensed
Display tracking information
Link to adult BNF
Link to children's BNF
Link to SPCs
Cytotoxic Drug
Controlled Drug
High Cost Medicine
Cancer Drugs Fund
NHS England
Homecare
CCG
Traffic Light Status Information
Status
Description
Secondary care only, not to be prescribed in primary care.
Specialist initiation with shared care guidance
Medicines which should be initiated in secondary care by the specialist with follow-on prescription and monitoring according to a specific Shared Care (SC) Guideline. Prescribing may be continued in primary care in line with a shared care guideline
Specialist initiation with shared care guidance Medicines which should be initiated in secondary care by the specialist with follow-on prescription and monitoring according to a specific Shared Care (SC) Guideline. Prescribing may be continued in primary care in line with a shared care guideline
Considered suitable for primary care prescribing following specialist initiation/recommendation.
Considered appropriate for prescribing in both secondary and primary care.
Suitable for initiation in primary care.